DNA ‘Marks’ Gastric Cancer Risk

DNA modification potentially useful as biomarker for gastric cancer risk

January 25, 2011 | Melissa Marino

Infection with the stomach-dwelling bacterium Helicobacter pylori is a strong risk factor for gastric cancer. But since about half of the world’s population is infected, and less than 1 percent of infected individuals develop cancer, other factors must contribute to gastric cancer risk.

Barbara Schneider, Ph.D., and colleagues are examining the role of epigenetic factors – modifications that alter gene expression, but do not affect the primary DNA sequence. They compared gastric biopsies from two Colombian populations – one with high risk of gastric cancer and one with lower risk – with similar prevalence of H. pylori infection.

In the Dec. 1 International Journal of Cancer, they report that regulatory regions (promoters) of two genes (RPRM and TWIST1) were more heavily modified (methylated) in the high-risk population compared to the low-risk population. Infection with more virulent bacterial strains was also associated with increased DNA methylation. The results suggest that DNA methylation could be a useful biomarker for determining gastric cancer risk.

For other research highlights from Vanderbilt University Medical Center laboratories, see ‘Aliquots‘ in the VUMC Reporter.

No Comments

No comments yet.

Sorry, the comment form is closed at this time.